Genetic tests in the insurance system: criteria for a moral evaluation
Poiesis and Praxis 1 (3):185-195 (2003)
Abstract
An increasing number of genetic tests are available as an early spin-off from human genetic research. Beyond their application in the context of medical diagnosis there are other possible domains of use: e.g. in the testing of individuals asking for life or health insurance. It is claimed that individuals with an increased genetic risk might have to pay higher premiums or, worse, might be unable to obtain insurance coverage at all. The main question discussed in this paper will be whether there is a right to health and/or life insurance coverage without prior genetic testing. The legal regulations of the use of genetic tests in the insurance system are various. While some countries in principle permit the use of (some) genetic tests for the calculation of actuarial risks, others banned genetic tests for non-medical uses; still other countries have not made any explicit provisions up to now. In the face of the attempted harmonisation of legal systems, as well as an increasing commercialisation of the international market for genetic tests, which neglects national borders, providing criteria for a moral evaluation of this issue appears to be a timely and urgent task. The view defended in this paper is that a right to health insurance without genetic testing is legitimised, insofar as health insurance belongs to the provision of elementary requirements, and insofar as the latter is everybody's moral right. On the other hand, it is implausible to postulate a right to life insurance without genetic testing â as long as life insurance is understood to be a part of one's provision of supplementary requirementsMy notes
Similar books and articles
Distinguishing genetic from nongenetic medical tests: Some implications for antidiscrimination legislation.Joseph S. Alper & Jon Beckwith - 1998 - Science and Engineering Ethics 4 (2):141-150.
The use of genetic test information in insurance: The argument from indistinguishability reconsidered.V. Launis - 2000 - Science and Engineering Ethics 6 (3):299-310.
Are genetic self-tests dangerous? Assessing the commercialization of genetic testing in terms of personal autonomy.Ludvig Beckman - 2004 - Theoretical Medicine and Bioethics 25 (5-6):387-398.
Reassessing insurers' access to genetic information: Genetic privacy, ignorance, and injustice.Eli Feiring - 2009 - Bioethics 23 (5):300-310.
Human Genes and Neoliberal Governance: A Foucauldian Critique.Antoinette Rouvroy - 2008 - Routledge-Cavendish.
The genetics revolution, economics, ethics and insurance.Patrick L. Brockett & E. Susan Tankersley - 1997 - Journal of Business Ethics 16 (15):1661-1676.
Genetic information: Consumers' right to privacy versus insurance companies' right to know a public opinion survey. [REVIEW]Shaheen Borna & Stephen Avila - 1999 - Journal of Business Ethics 19 (4):355 - 362.
Argumentation and risk communication about genetic testing: Challenges for healthcare consumers and implications for computer systems.Nancy L. Green - 2012 - Journal of Argumentation in Context 1 (1):113-129.
Genetic Nondiscrimination and Health Care as an Entitlement.B. M. Kious - 2010 - Journal of Medicine and Philosophy 35 (2):86-100.
Genetic Screening and Disability Insurance: What Can We Learn From The Health Insurance Experience?Nancy Kass & Amy Medley - 2007 - Journal of Law, Medicine and Ethics 35 (s2):66-73.
Genetic Testing and the Future of Disability Insurance: Thinking about Discrimination in the Genetic Age.Paul Steven Miller - 2007 - Journal of Law, Medicine and Ethics 35 (s2):47-51.
The ethical challenges of direct-to-consumer genetic testing.Cheryl Berg & Kelly Fryer-Edwards - 2008 - Journal of Business Ethics 77 (1):17 - 31.
Analytics
Added to PP
2010-09-02
Downloads
15 (#700,732)
6 months
1 (#452,962)
2010-09-02
Downloads
15 (#700,732)
6 months
1 (#452,962)
Historical graph of downloads
Citations of this work
Is there a need or space for gene technology ethics: An Australian perspective.Don Chalmers - 2008 - In Darryl R. J. Macer (ed.), Asia-Pacific Perspectives on Biotechnology and Bioethics. Unesco Bangkok. pp. 1888.